Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03211728
Other study ID # 4-2017-0415
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date July 19, 2017
Est. completion date February 8, 2019

Study information

Verified date February 2019
Source Yonsei University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The investigators hypothesize that perioperative oral administration of pregabalin would reduce postoperative pain and produce reduction in postoperative opioid consumption after anterior cruciate ligament (ACL) reconstruction . Patients are randomly assign to 1 of 2 groups. The placebo group receive placebo capsules 1 hour before surgery and 12 hours after initial dose. The pregabalin group receive pregabalin 150 mg, respectively at the same points.


Recruitment information / eligibility

Status Completed
Enrollment 96
Est. completion date February 8, 2019
Est. primary completion date February 8, 2019
Accepts healthy volunteers No
Gender All
Age group 20 Years to 65 Years
Eligibility Inclusion Criteria:

- age between 20-65 years

- physical condition type I or II in ASA (American Society of Anesthesiology)

Exclusion Criteria:

- patients of ASA classification 3 or more

- with a history of cardiovascular or respiratory disease

- dizziness or frequent headache

- active alcohol or drug usage,

- intake of any analgesics daily or 48 hours before surgery

- impaired renal and/or hepatic function

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
pregabalin
The intervention group receive pregabalin 150 mg 1 hour before surgery and 12 hours after initial dose.
placebo
The placebo group receive placebo 150 mg 1 hour before surgery and 12 hours after initial dose.

Locations

Country Name City State
Korea, Republic of Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institue, Yonsei Universiy College of Medicine Seoul

Sponsors (1)

Lead Sponsor Collaborator
Yonsei University

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary Postoperative pain scores Visual analog scale (VAS) score = 0-100 mm 12 hours after surgery
Primary Postoperative pain scores Visual analog scale (VAS) score = 0-100 mm 24 hours after surgery
Primary Postoperative pain scores Visual analog scale (VAS) score = 0-100 mm 36 hours after surgery
Primary Postoperative pain scores Visual analog scale (VAS) score = 0-100 mm 2 weeks after surgery
Secondary Opioid consumption the first 48 hours after surgery
See also
  Status Clinical Trial Phase
Completed NCT03417479 - Gabapentin Premedication for ACL Reconstruction: RCT
Withdrawn NCT03562299 - OrthoPureā„¢ XT Pilot Clinical Study N/A
Recruiting NCT04462458 - M-ARS ACL Post-marketing Surveillance Study
Recruiting NCT06382324 - The Psychological Impact of Mindfulness Intervention to Anterior Cruciate Ligament Reconstruction N/A
Recruiting NCT06347523 - VR-Based Preoperative Rehabilitation Program for Patients Undergoing Anterior Cruciate Ligament (ACL) Reconstruction N/A